Translating gut microbiome research into therapies for type 1 diabetes
Shanti P. Kok, Max Nieuwdorp, Elena Rampanelli · 2026
Read Translating gut microbiome research into therapies for type 1 diabetes by Shanti P. Kok, Max Nieuwdorp, Elena Rampanelli (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13559605.txt.
Description
Kok and co-authors published a review paper in 2026 on turning gut microbiome science into treatments for type 1 diabetes. The disease destroys insulin-making cells, and gut microbe shifts are consistently seen alongside it. The review gathers what is known about the microbial pathways that go off track, covering fatty acid, bile acid, and amino acid products.
It then surveys therapies from fiber-like prebiotics to stool transplants in animals and patients. Some trials improved sugar control and immune markers, but results vary widely with the population studied. The authors call for broader therapy options and sturdier trials before microbiome care joins standard diabetes practice.
Catalog record
| CREATOR | Shanti P. Kok, Max Nieuwdorp, Elena Rampanelli |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 71 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |